Jack Womack

2 weeks ago | law.com | Jack Womack

A&O Shearman and Freshfields Face Off in Fast Fashion Court BattleShein and Temu, giants of the fast fashion retail industry, are locked in disputes in the U.K. and the U.S.May 22, 2025 at 04:58 AM

2 weeks ago | law.com | Jack Womack

89 different nationalities were represented in cases heard by London's commercial court in the last year, according to the report. May 21, 2025 at 07:24 AM

2 weeks ago | law.com | Jack Womack

Burford Capital no longer uses London as its default arbitration seat due to the continuing uncertainty caused by the Supreme Court’s PACCAR decision, its chief executive officer has said. Speaking at a media briefing in London, Christopher Bogart said the litigation funder is making greater use of other arbitration destinations for its cases, such as Singapore, Paris, and New York.

2 weeks ago | law.com | Jack Womack

To many observers, much of the legal industry’s hasty retreat from diversity, equity, and inclusion (DEI) has been a pretty unedifying spectacle. Law.com has reported extensively on how the ideals which many law firms championed for years have begun to disappear from their websites and public statements, prompting unease, if not surprise, among many lawyers.

3 weeks ago | law.com | Jack Womack

Pharma giant GlaxoSmithKline has enlisted Cleary Gottlieb Steen & Hamilton to advise on its acquisition of a liver disease medication from Boston Pharmaceuticals, which could reach a value of up to $2 billion. GSK confirmed the transaction and Cleary's role on the London Stock Exchange on Wednesday, as it said it would pay $1.2 billion upfront for efimosfermin—a liver disease drug in late-stage trials.